Related Experiment Video
Updated: Feb 14, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Cardiac troponin for predicting all-cause mortality in patients with acute ischemic stroke: a meta-analysis
Yu Fan1, Menglin Jiang1, Dandan Gong1
1Institute of Molecular Biology and Translational Medicine, The Affiliated People's Hospital, Jiangsu University, Zhenjiang, Jiangsu 212002, P.R. China.
Insights
Elevated cardiac troponin levels in acute ischemic stroke patients significantly increase the risk of all-cause mortality. This finding suggests cardiac troponin testing can aid in early death risk stratification for stroke patients.
Area of Science:
- Cardiology
- Neurology
- Biomarkers
Background:
- Cardiac troponins are established biomarkers for cardiac injury.
- The prognostic significance of elevated cardiac troponins in acute ischemic stroke (AIS) patients remains debated.
- Early identification of mortality risk in AIS patients is crucial for timely intervention.
Purpose of the Study:
- To conduct a meta-analysis investigating the association between elevated cardiac troponin and all-cause mortality in patients with AIS.
- To determine the prognostic value of cardiac troponin elevation in predicting mortality risk following acute ischemic stroke.
Main Methods:
- Systematic literature search of PubMed and Embase databases up to April 2017.
- Inclusion of observational studies reporting on baseline cardiac troponin-T (cTnT) or troponin-I (cTnI) elevation and all-cause mortality in AIS patients.
- Pooled analysis using a random-effects model to calculate adjusted risk ratios (RR) and 95% confidence intervals (CI).
Main Results:
- Twelve studies comprising 7905 AIS patients met the inclusion criteria.
- Elevated cardiac troponin was significantly associated with increased all-cause mortality (RR: 2.53; 95% CI: 1.83-3.50).
- The association was stronger for in-hospital mortality (RR: 3.54; 95% CI: 2.09-5.98), with both cTnT and cTnI showing similar prognostic value.
Conclusions:
- Baseline elevation of cardiac troponin (cTnT or cTnI) independently predicts a higher risk of all-cause mortality in acute ischemic stroke patients.
- Cardiac troponin determination upon admission may facilitate early risk stratification for mortality in this population.
- These findings underscore the importance of cardiac biomarker assessment in stroke management.
Abstract:
Cardiac troponins are specific biomarkers of cardiac injury. However, the prognostic usefulness of cardiac troponin in patients with acute ischemic stroke is still controversial. The objective of this meta-analysis was to investigate the association of cardiac troponin elevation with all-cause mortality in patients with acute ischemic stroke. PubMed and Embase databases were searched for relevant studies up to April 31, 2017. All observational studies reporting an association of baseline cardiac troponin-T (cTnT) or troponin-I (cTnI) elevation with all-cause mortality risk in patients with acute ischemic stroke were included. Pooled adjusted risk ratio (RR) and corresponding 95% confidence interval (CI) were obtained using a random effect model. Twelve studies involving 7905 acute ischemic stroke patients met our inclusion criteria. From the overall pooled analysis, patients with elevated cardiac troponin were significantly associated with increased risk of all-cause mortality (RR: 2.53; 95% CI: 1.83-3.50). The prognostic value of cardiac troponin elevation on all-cause mortality risk was stronger (RR: 3.54; 95% CI: 2.09-5.98) during in-hospital stay. Further stratified analysis showed elevated cTnT (RR: 2.36; 95% CI: 1.47-3.77) and cTnI (RR: 2.79; 95% CI: 1.68-4.64) level conferred the similar prognostic value of all-cause mortality. Acute ischemic stroke patients with elevated cTnT or cTnI at baseline independently predicted an increased risk of all-cause mortality. Determination of cardiac troponin on admission may aid in the early death risk stratification in these patients.
More Related Videos
07:34Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research
Published on: December 15, 2023
07:40Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training
Published on: October 10, 2019
Related Concept Videos
Cardiac Output II: Effect of Stroke Volume on Cardiac Output
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
Cardiac Output and Stroke Volume
In an average resting adult male, the typical cardiac...
Predicting Molecular Geometry
Directing Effect of Substituents: meta-Directing Groups
Prediction Intervals
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y.
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...